Immunocore to report second quarter 2025 financial results and host call on August 7, 2025
Immunocore to report second quarter 2025 financial results and host call on August 7, 2025 GlobeNewswire July 31, 2025 (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, July 31, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for […]